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Abstract
Background: Hemiballism/hemichorea commonly occurs as a result of a lesion in the subthalamic region.
Case Report: A 38-year-old male with Parkinson’s disease developed intractable hemiballism in his left extremities due to a small lesion that was located adjacent
to the right deep brain stimulation (DBS) lead, 10 months after bilateral subthalamic nucleus (STN)-DBS placement. He underwent a right globus pallidus internus
(GPi)-DBS lead implantation. GPi-DBS satisfactorily addressed his hemiballism.
Discussion: This case offered a unique look at basal ganglia physiology in human hemiballism. GPi-DBS is a reasonable therapeutic option for the treatment of
medication refractory hemiballism in the setting of Parkinson’s disease.
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Introduction
Hemiballism is an involuntary hyperkinetic movement disorder
characterized by unilateral, violent, and flinging movements of the
limbs1 and can result from a lesion in the contralateral or ipsilateral
subthalamic nucleus (STN), the subthalamic region, the thalamus, and
also several other brain regions.2–4 Hemiballism is more severe when
resulting from an STN lesion than when caused by involvement of
other brain regions. In medically refractory cases, surgical interven-
tions such as thalamotomy5,6 and pallidotomy7,8 have been applied
sparingly, since it is generally believed that the hyperkinetic move-
ments will lessen over time even without intervention.4,9 We report a
unique case where deep brain stimulation (DBS) of the globus pallidus
internus (GPi-DBS) was utilized to suppress hemiballism resulting from
a subthalamic stroke. This patient had bilateral STN-DBS performed
in the remote past for Parkinson’s disease (PD), and a new stroke was
discovered to be adjacent to one of the previously implanted
stimulators. We present the details of the case and also the
physiological recordings from the DBS surgery.
Case report
A 38-year-old male with young-onset PD was initially referred to
the University of Florida Center for Movement Disorders and
Neurorestoration for evaluation. He had initially developed left-sided
bradykinesia, rigidity, and tremor, and was treated with carbidopa/
levodopa 25/100, one tablet, five times daily, which resulted in
excellent benefit to his PD symptoms. Over the years he developed
intolerable wearing off, and severe peak-dose dyskinesia that could not
be improved by altering the dose (carbidopa/levodopa 25/100, two
tablets, five times daily) and combinations of medications, including
rasagiline l mg and entacapone 200 mg five times daily. His Unified
Parkinson’s Disease Rating Scale (UPDRS) motor score was 11 (on
medication) and 25 (off medication).
He underwent a simultaneous, bilateral, STN-DBS implantation at
the age of 44 years. Microelectrode recording (three passes on each
hemisphere) was performed without anesthesia and was followed by
macro-test stimulation. He reported excellent immediate implantation
effects, with complete tremor suppression in both hands. One month
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following his lead implantation, subclavicular generators (Soletra,
Medtronic, Minneapolis, MN) were implanted and connected to the
DBS leads under general anesthesia. The placement of the leads was
confirmed postoperatively by a computed tomography (CT) scan fused
to preoperative magnetic resonance imaging (MRI) (ventral lead tips:
right 6.1 mm posterior, 10.6 mm lateral, 7 mm inferior; left 8.6 mm
posterior, 10.1 mm lateral, 8 mm inferior). The lead locations were
calculated as relative to the midpoint of the anterior posterior
commissure (AC–PC) line. His chronic stimulation parameters were
left STN, 2(2)C(+), 2.4 V, 90 ms, 135 Hz; right STN, 1(2)3(+), 2.0 V,
90 ms, 130 Hz. The postoperative UPDRS motor score was 33 (off
medication/off stimulation), 27 (on medication/off stimulation), 24 (off
medication/on stimulation), and 6 (on medication/on stimulation). At
that time he reduced the dose of entacapone to 200 mg, taking only
one tablet at night. He reported no ‘‘off’’ medication time, and he had
minimal dyskinesia for the subsequent 9 months.
Approximately 10 months after DBS placement, while on vacation
with family, he developed sudden-onset, severe left arm and leg
dyskinesia. He turned off his DBS devices, and weaned off of all his PD
medications, but the movements persisted. Four weeks later, he was
admitted to the hospital for inpatient management of the ballistic
movements. To suppress this hyperkinetic movement, lorazepam,
10 mg daily in three divided doses and olanzapine 5 mg three times
daily were continued for 1 month, but these were only moderately
helpful. The addition of clozapine, also in an attempt to control the
hyperkinesia, only improved the hemiballism minimally.
After discussing the risks and benefits of potential surgery, a decision
was made to place a right GPi-DBS device. As part of the preoperative
protocol, high-resolution MRI was done and revealed a new T2 high-
and T1 low-intensity lesion within the right STN that was directly
adjacent to the right STN-DBS lead (Figure 1).
Microelectrode recording was performed without anesthesia, and
single unit and local field potential (LFP) recordings were collected
during the procedure. The recordings were split into two digitally
filtered channels. Single units were sampled at 12.2 kHz and filtered
from 500 Hz to 6 kHz. LFPs were sampled at 400.2 Hz and filtered
from 0.5 to 200 Hz. During two passes, 14 single units were recorded
from the target area, beginning at 8.3 and 9.7 mm from final depth
(final depth was defined on the computer as the ventral/bottom of the
optic track). The mean firing rate of the isolated neurons was
46.1¡29.2 Hz (n514). The mean coefficient of variance for the inter-
spike interval was 1.19¡0.28 ms. The mean burst index was
0.30¡0.3. Figure 2 illustrates a representative microrecording
(Figure 2A) and histogram of inter-spike interval (Figure 2B).
Throughout both microelectrode passes, a high-pass hardware filter
(125 Hz, 20 db/decade) was disabled to allow LFP recordings. Signal
analysis was performed using MATLAB 7.7 software (Mathworks,
Natick, MA). Total power spectrum analysis for each LFP was
accomplished utilizing short time Fourier transform with a length of
4,096, and spectrograms were computed using a 256-point Hanning
window with 50% overlap. The power spectra analysis revealed that
strong beta activity was present at the baseline. During one recording,
stimulation from the previous implant in the left STN was enabled for
30 s. This stimulation had no effect on the beta band; on the other
hand, theta band activity was increased (Figure 2C). Linear regression
analysis suggested that theta would return to baseline levels 54.5 s after
cessation of stimulation, though this was not recorded.
After microelectrode recording, macrostimulation was performed to
confirm thresholds for side effects and benefits, and a 3387 DBS lead
(Medtronic) was implanted and connected to the existing right-sided
Soletra implantable pulse generators (IPGs) (Medtronic). A left-sided
Soletra IPG was changed to a Kinetra IPG (Medtronic, Minnesota),
which was then connected to the existing bilateral STN-DBS leads.
The GPi lead was immediately activated and the stimulation settings
were adjusted at 1 month to 1(2)C(+), 3.3 V, 90 ms, 135 Hz on right
GPi, 2(2)C(+) 2.2 V, 60 ms, 135 Hz for the left STN-DBS, and
5(2)7(2) 1.5 V, 90 ms, 135 Hz for the right STN-DBS. The lead
location was confirmed by postoperative CT–MRI fusion (ventral tip:
0.4 mm posterior, 21.5 mm lateral, 7.2 mm inferior relative to the
midpoint of the AC–PC line). The hemiballistic movements abated in
the operating theater during testing and the patient noticed
improvement immediately on activation. By the end of the first
postoperative week, the hemiballistic movements had completely
resolved. He reported no dyskinesia or wearing off and was taking
carbidopa/levodopa 25/100, one tablet, three times daily.
Discussion
There were several important observations in this case. First, the
STN stroke with resulting hemiballism was located adjacent to the
previously placed DBS lead. This finding was unique, and it is
Figure 1. STN infarction adsacent to the DBS lead. Subthalamic nucleus
infarction (red arrow) is seen adjacent to the previously placed deep brain
stimulator.
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unknown whether the DBS implantation itself influenced the
occurrence of the stroke and when the stroke occurred. Second, we
were able to treat the disabling movement disorder by adding a GPi-
DBS system to the existing bilateral STN-DBS. To our knowledge,
there is no existing report of GPi-DBS as applied for hemiballism,
although thalamotomy5,6 and pallidotomy7,8 have been performed by
other groups. Recently, Allert et al.10 reported additional GPi-DBS
rescue leads successfully applied for severe choreaform dyskinesias
after a few years of STN-DBS implantation. The immediate cessation
of this patient’s movement matched the observations detailed in the
previously published case reports that have utilized other surgical
approaches. This current case offered us an opportunity to examine
the human physiology, and to compare the physiology with the
existing model of hemiballism.
The classical basal ganglia-thalamocortical motor circuit model has
been previously proposed and can be applied to ballism.11 Using the
model, in hyperkinetic movements such as ballism, lesions within the
circuitry have been postulated to reduce excitatory output from the STN
that is directed to the GPi. Overall the model predicts a repeated word
diminished basal ganglia output and enhanced thalamocortical activa-
tion.2,12,13 The lesion in this area of basal ganglia has been postulated to
produce ballistic movements. Our current DBS case offered us a unique
opportunity to record from the pallidum, and to stimulate the STN in a
patient with ballism.
In previous studies, Suarez et al.7 reported that the firing rate of GPi
in patients with hemiballism (30¡5 Hz) was lower than the observed
rate in PD (on state552¡6, off state596¡8). Similarly, Vitek et al.8
also reported the mean firing rate of GPi was lower in patients with
hemiballism (33.7¡21.2 Hz) especially when compared with dystonia
(50¡20.5 Hz). In Huntington’s disease, which is known to be
associated with chorea and in rare cases ballism, there has been a
widely reported distribution of firing rates, but without correlation to
chorea or hemiballism (29–81 Hz).14–16
In our case, it is possible that the patient initially had a typical firing
rate and pattern in his basal ganglia indicative of PD, and then later
developed a different firing pattern post stroke. Our intraoperative
microrecording revealed a slightly lower activity from GPi than is
typically observed in PD (46.1¡29.2 compared with 70–95 Hz).14,17–19
The GPi firing rate in our case was higher than in the previously
reported hemiballism cases.7,8 On the other hand, the burst index in our
case (0.30¡0.3) was lower than previously reported (1.5–2.5).20,21 The
markedly reduced burst index in our case may have been a result of
pathological disruption of inputs from the STN. It is also possible that
we observed heterogeneity from neurons recorded in the GPi, especially
given the low sample number.
Abnormal synchronization of basal ganglia activity has been
suggested to be associated with hyperkinetic movements.7 Recently it
has been shown that exaggerated beta oscillations in the 14–30 Hz
bands are prominent and have been reported in STN PD cases22–27
and also in GPi PD cases.22,24,28–30 Beta synchronization in the basal
ganglia circuitry has been shown to be suppressed by dopaminergic
medication22,24,25,29,30 and by high-frequency STN stimulation.23,31–33
The suppression of oscillatory synchronization in the pallidum has also
been correlated with levodopa-induced dyskinesia.34 Our analysis of
the LFP revealed the presence of a strong beta band that was similar to
a previous report.35 However, the beta band in our case was not
suppressed by STN stimulation, which would not be the typical finding
in PD, and we suspect the stroke altered the physiology. Additionally,
Figure 2. Intraoperative physiological recordings. The representative
microrecording in globus pallidus internus (A) and histogram of inter-spike interval
(B). (C) Spectral analysis of local field potential during stimulation. Spectrogram
showing the occurrence of the stimulation artifact (107 Hz) from the previous
ipsilateral deep brain stimulation implant in the subthalamic nucleus and
oscillatory activity in the time vicinity of the stimulation. Quantification of theta
(4–8 Hz) and beta (12–25 Hz) band oscillatory power revealed an increase in theta
band activity.
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theta band activity in GPi was induced by stimulation. In dystonia
patients, the low-frequency theta band is reported to be predominant
in GPi and STN.30,36,37 Similar to dystonia, low-frequency oscillations
in basal ganglia may play a role in hemiballism or dyskinesia, but this
hypothesis will need to be tested by a future study.
In conclusion, although only a single case, GPi-DBS was a
reasonable therapeutic option for the treatment of medication
refractory hemiballism in the setting of PD. More detailed human
physiological studies of ballism in patients with and without PD are
necessary, and may help us to better understand this entity.
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